<SEC-DOCUMENT>0001193125-22-112995.txt : 20220523
<SEC-HEADER>0001193125-22-112995.hdr.sgml : 20220523
<ACCEPTANCE-DATETIME>20220421160951
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-22-112995
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BlackRock Health Sciences Trust
		CENTRAL INDEX KEY:			0001314966
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809
		BUSINESS PHONE:		(888) 825-2257

	MAIL ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>BlackRock Health Sciences Trust</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g269284g0421134142318.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">787 Seventh Avenue</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">New York, NY 10019-6099</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Tel: 212 728 8000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Fax: 212 728 8111</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;21, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>VIA
EDGAR</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Orlic </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Investment
Management </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities and Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street,
NE </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">BlackRock Health Sciences Trust </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(Securities Act File No. 333-263527, Investment Company Act File
<FONT STYLE="white-space:nowrap">No.&nbsp;811-21702)</FONT> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Response to Staff Comments </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Mr.&nbsp;Orlic: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of BlackRock Health Sciences
Trust (the &#147;Trust&#148;), this letter responds to comments provided by the staff of the Division of Investment Management (the &#147;Staff&#148;) of the Securities and Exchange Commission to the undersigned via telephone on April&nbsp;14, 2022
regarding the registration statement on Form <FONT STYLE="white-space:nowrap">N-2</FONT> (the &#147;Registration Statement&#148;) for the Trust filed on March&nbsp;14, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the convenience of the Staff, the comments are set out below. We have discussed the Staff&#146;s comments with representatives of the Trust. The
Trust&#146;s responses to the Staff&#146;s comments are set out immediately under the restated comment. Please note that we have not independently verified information provided by the Trust. The Trust anticipates filing these changes in a <FONT
STYLE="white-space:nowrap">Pre-Effective</FONT> Amendment (the &#147;Amendment&#148;) to the Registration Statement. Unless otherwise indicated, defined terms used herein have the meanings set forth in the Registration Statement. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;1</U>: <I> </I></P></TD>
<TD><I>Prospectus &#150; Summary of Trust Expenses.</I> <I>The Staff notes that footnote 4 to the fee table states as follows: </I><I>&#147;</I><I>Other Expenses have been restated to reflect current fees.</I><I>&#148;</I><I> Please advise to the
particulars as to why Other Expenses have been restated.</I> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;1</U>: </P></TD>
<TD>The fee table will be revised in the Amendment and footnote 4 will be deleted. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B<SMALL>RUSSELS</SMALL>
&nbsp;&nbsp;&nbsp;&nbsp; C<SMALL>HICAGO</SMALL> &nbsp;&nbsp;&nbsp;&nbsp;F<SMALL>RANKFURT</SMALL> &nbsp;&nbsp;&nbsp;&nbsp;H<SMALL>OUSTON</SMALL> &nbsp;&nbsp;&nbsp;&nbsp;L<SMALL>ONDON</SMALL> L<SMALL>OS</SMALL>
A<SMALL>NGELES&nbsp;&nbsp;&nbsp;&nbsp;</SMALL> M<SMALL>ILAN</SMALL> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">N<SMALL>EW</SMALL> Y<SMALL>ORK</SMALL>
&nbsp;&nbsp;&nbsp;&nbsp;P<SMALL>ALO</SMALL> A<SMALL>LTO</SMALL> &nbsp;&nbsp;&nbsp;&nbsp;P<SMALL>ARIS</SMALL> R<SMALL>OME</SMALL> &nbsp;&nbsp;&nbsp;&nbsp;S<SMALL>AN</SMALL> F<SMALL>RANCISCO</SMALL> &nbsp;&nbsp;&nbsp;&nbsp;W<SMALL>ASHINGTON</SMALL>
</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 21, 2022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;2</U>: <I> </I></P></TD>
<TD><I>Prospectus &#150; Description of Shares &#150; Common Shares. Please fill in the missing information in the NYSE table and update the table to include information from March</I><I></I><I>&nbsp;31, 2022.</I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;2</U>: </P></TD>
<TD>The requested changes will be made in the Amendment. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;3</U>: <I> </I></P></TD>
<TD><I>Prospectus &#150; Certain Provisions in the Agreement and Declaration of Trust and Bylaws. The Staff notes that this section of the Prospectus contains information with respect to anti-takeover provisions. Please briefly describe the
anti-takeover provisions in the Prospectus Summary section.</I> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;3</U>: </P></TD>
<TD>The requested change will be made in the Amendment. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;4</U>: </P></TD>
<TD><I>Prospectus &#150; Plan of Distribution. Please clarify in the last sentence of the fourth paragraph that an underwriter may only purchase common shares remaining unsubscribed after the rights offering if the rights were to purchase shares
above net asset value.</I> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;4</U>: </P></TD>
<TD>The above-referenced sentence will be deleted from the Amendment. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;5</U>: <I> </I></P></TD>
<TD><I>Prospectus Supplement &#150; Description of the Rights Offering &#150; Over-Subscription Privilege. Please disclose that, in the event that the Trust&#146;s per share NAV at the end of the Subscription Period is greater than the subscription
price (i.e., Common Shares will be issued at a price below the Trust&#146;s then current NAV), the over-subscription shares issued will not result in the ratio of the Rights offering exceeding one new share for each three Rights held.</I>
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;5</U>: </P></TD>
<TD>The requested disclosure will be added in the Amendment. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;6</U>: <I> </I></P></TD>
<TD><I>Prospectus Supplement &#150; Description of the Rights Offering &#150; Payment for Shares. Please conform the language that discusses the rights reserved by the Trust if a holder of rights does not make payment of all amounts due to the
disclosure comments that the Staff discussed with attorneys of Willkie Farr</I><I></I><I>&nbsp;&amp; Gallagher LLP in respect of a separate filing.</I> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;6</U>: </P></TD>
<TD>The requested changes will be made in the Amendment. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;7</U>: <I> </I></P></TD>
<TD><I>Prospectus Supplement &#150; Foreign Restrictions. Please revise the disclosure to indicate how foreign holders can participate in the offering, or advise how the disclosure is consistent with Section</I><I></I><I>&nbsp;23(b)(1) to exclude
them from the offering.</I> </TD></TR></TABLE>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 21, 2022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;7</U>: </P></TD>
<TD>The Trust will replace the disclosure in the aforementioned section as follows: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="28%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Offering documents, including Subscription Certificates, will not be mailed to Record Date Shareholders whose addresses are outside the United States (for these purposes, the United States includes the District of
Columbia and the territories and possessions of the United States) or who have an APO or FPO address (the &#147;Foreign Shareholders&#148;) if such mailing cannot be made into the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction without
additional registration and incurring other expense that the Board has determined is not in the best interest of the Trust and its shareholders. In such cases, unless determined to be not in the best interest of the Trust and its shareholders in
accordance with the previous sentence, the Subscription Agent will send a letter via regular mail to Foreign Shareholders who own Common Shares directly (&#147;Direct Foreign Shareholders&#148;), as opposed to in &#147;street name&#148; with a
broker or other financial intermediary, to notify them of the Rights offering. Direct Foreign Shareholders who wish to exercise their Rights should contact the Information Agent, as described above under &#147;Information Agent,&#148; to facilitate
the exercise of such Rights and for instructions or any other special requirements that may apply in order for such Direct Foreign Shareholder to exercise its Rights. Direct Foreign Shareholders who wish to sell their Rights should contact the
Subscription Agent and follow the procedures described above under &#147;Sale of Rights.&#148; Direct Foreign Shareholders are encouraged to contact the Trust or the Subscription Agent as far in advance of the Expiration Date as possible to ensure
adequate time for their Rights to be exercised or sold. Foreign Shareholders who own Common Shares in &#147;street name&#148; through a broker or other financial intermediary should contact such broker or other financial intermediary with respect to
any exercise or sale of Rights. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="22%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Trust respectfully submits that foreign shareholders are not excluded from participation in an offering of Rights. Any foreign shareholder may exercise or sell (in a transferable Rights offering) any Rights to which
they are entitled. The Trust is simply not undertaking in the Registration Statement to register the offering of Rights in any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction. In the event a shareholder is unable to exercise their
Rights due to local laws, the Trust has established a mechanism that seeks to allow shareholders located in foreign jurisdictions to realize the value of the Rights. These points will be disclosed to shareholders as set out above. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;8</U>: <I> </I></P></TD>
<TD><I>Prospectus Supplement &#150; Plan of Distribution &#150; Distribution Arrangements. If the Dealer Manager and selling members may be engaging in stabilizing activities, please disclose this and discuss that this may have the effect of
depressing or retarding the market price of the common stock.</I> </TD></TR></TABLE>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 21, 2022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 4 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;8</U>: </P></TD>
<TD>The requested disclosure will be added in the Amendment in brackets. While not currently expected, to the extent any stabilizing activities are engaged in with respect to a particular rights offering, the disclosure will be finalized and
included in a prospectus supplement. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;9</U>: <I> </I></P></TD>
<TD><I>Part C. Please provide the Staff with a form of the legal opinion required by Item 25(2)(l) of Form <FONT STYLE="white-space:nowrap">N-2</FONT> prior to requesting effectiveness.</I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;9</U>: </P></TD>
<TD>A draft of the legal opinion to be filed with the Amendment was provided to the Staff via email on April&nbsp;14, 2022. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Comment No.</U><U></U><U>&nbsp;10</U>: </P></TD>
<TD><I>Part C. Please revise Item 34 (&#147;Undertakings&#148;) of the Part C to include undertaking no. 5 of Form <FONT STYLE="white-space:nowrap">N-2.</FONT></I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="22%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><U>Response No.</U><U></U><U>&nbsp;10</U>: </P></TD>
<TD>The requested change will be made in the Amendment. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please do not hesitate to contact me at (212)
<FONT STYLE="white-space:nowrap">728-8037</FONT> if you have comments or if you require additional information regarding the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Respectfully submitted, </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>/s/ Stacey P.
Ruiz&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stacey P. Ruiz </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dean A. Caruvana, Esq., BlackRock, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Elliot J. Gluck, Esq., Willkie Farr&nbsp;&amp; Gallagher LLP </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Bissie Bonner, Esq., Willkie Farr&nbsp;&amp; Gallagher LLP </P></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g269284g0421134142318.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g269284g0421134142318.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  7 4L# 2(  A$! Q$!_\0
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M\ZZ0,H<1/MR1D\XV]!ZU!XH@O-8\=^#M;LK.22QTUII+ARZ*0KHNW +9-%%
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F,;P.><8_'MFMUO GAB2226?1[:XFD=G>69=SNQ))))^M%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
